CG
TARO

Cutler Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Cutler Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-420
Closed -$16K – 5876
2022
Q1 		$18K Sell
420
-680
-62% -$31.8K ﹤0.01% 3167
2021
Q4 		$55K Buy
1,100
+100
+10% +$5.6K ﹤0.01% 2338
2021
Q3 		$63K Hold
1,000
– – ﹤0.01% 2319
2021
Q2 		$71K Hold
1,000
– – ﹤0.01% 2182
2021
Q1 		$73K Hold
1,000
– – ﹤0.01% 2034
2020
Q4 		$73K Sell
1,000
-100
-9% -$6.43K ﹤0.01% 1742
2020
Q3 		$60K Hold
1,100
– – ﹤0.01% 1684
2020
Q2 		$73K Sell
1,100
-200
-15% -$13.4K ﹤0.01% 1496
2020
Q1 		$79K Hold
1,300
– – ﹤0.01% 1471
2019
Q4 		$114K Buy
+1,300
New +$110K 0.01% 1133
2019
Q1 		– Sell
-100
Closed -$8K – 4917
2018
Q4 		$8K Sell
100
-251
-72% -$24.2K ﹤0.01% 2686
2018
Q3 		$34K Hold
351
– – ﹤0.01% 1870
2018
Q2 		$40K Sell
351
-549
-61% -$60.3K ﹤0.01% 1751
2018
Q1 		$88K Hold
900
– – 0.01% 1275
2017
Q4 		$94K Buy
900
+800
+800% +$87.9K ﹤0.01% 1415
2017
Q3 		$11K Buy
+100
New +$10.9K ﹤0.01% 3756
2016
Q3 		– Sell
-300
Closed -$39.7K – 7538
2016
Q2 		$43K Sell
300
-700
-70% -$99.3K ﹤0.01% 2522
2016
Q1 		$143K Buy
+1,000
New +$142K 0.01% 1283

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cutler Group's TARO Position: Q2 2022 in Review

Cutler Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2022, closing a stake of 420 shares — an estimated $16K sold.

Cutler Group first reported a position in TARO in Q1 2016 and held it in 18 quarters. The position peaked at $143K in Q1 2016. 72 funds tracked by Wall St. Rank hold TARO as of Q2 2022.

  • Cutler Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 420 Taro Pharmaceutical Industries Ltd. shares in Q2 2022, an estimated $16K.
  • Cutler Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 18 quarters.
  • Cutler Group's Taro Pharmaceutical Industries Ltd. position peaked at $143K in Q1 2016.
  • 72 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.